my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
07-03-2011: BRAIN AG and the DECHEMA Society for Chemical Engineering and Biotechnology in Frankfurt have announced a collaboration in the biotechnological production of perillic acid.
This patented natural monoterpene is owned by BRAIN and will be used in a wide range of applications as a bioactive compound in cosmetic products.
The cooperation is aimed at advancing further development of an integrated bio-process for efficient microbial (+)-perillic acid synthesis from the cheap precursor (+) limonene, developed by PD Dr. Jens Schrader and his team at DECHEMA. The compound (+) limonene is extracted in large quantities from orange peel.
By combining the competencies in strain and process optimisation as well as Scale-Up at the Karl-Winnacker-Institute of the DECHEMA, with the microbiological and molecular biological methods of BRAIN, this project is aimed at developing an integrated bio-process for effective technical production.
Contact / Request information
Request further information free of charge:
Watchlist
This is where you can add this news to your personal favourites
BRAIN-led industrial NatLifE 2020 innovation alliance started after receipt of approval
As the industrial coordinator of the innovation alliance, the biotechnology company BRAIN AG has announced that the Natural Life Excellence Network 2020 (NatLifE 2020) innovation alliance is the first alliance to receive the official approval letter under the “Industrial Biotechnology Innov ... more
BRAIN expands its IP Portfolio with bioactive Compound MMPI
BRAIN AG has announced the expansion of its IP portfolio to include the MMPI (matrix metalloproteinase inhibitor) peptide. Now owned by BRAIN, the recombinant human bioactive molecule will be manufactured by BRAIN as a proprietary bioactive compound going forward and exclusively used in cos ... more
BRAIN announces €60m round of financing to expand its buy-and-build strategy
The supervisory board and the board of management of the biotechnology company BRAIN AG agreed on a €60m capital increase during a meeting of the supervisory board held on 19 November 2012. The capital increase helps pave the way for the implementation of BRAIN’s “buy-and-build” industriali ... more
BRAIN Biotechnology Research And Information Network AG
BRAIN AG is an industrial “white” biotech company which discovers and develops novel bioactive natural compounds and proprietary enzymes for its partners and customers in the chemical and pharmaceutical industries, as well as the food and cosmetics industries. With its unique approach to th ... more
BRAIN and DECHEMA cooperate in the biotechnological production of perillic acid
BRAIN AG and the DECHEMA Society for Chemical Engineering and Biotechnology in Frankfurt have announced a collaboration in the biotechnological production of perillic acid. This patented natural monoterpene is owned by BRAIN and will be used in a wide range of applications as a bioactive co ... more
Cologne Paper available online
The German Presidency of the Council of the European Union recently organized a high-level conference on biotechnology titled 'En Route to the Knowledge-Based Bio-Economy'. Renowned experts from science and industry had been invited to contribute to an expert paper which outlines the perspe ... more
Modern biology follows the trends in the chemical and physical sciences to use quantitative mathematical models for the description of complex cellular behavior. Concepts from molecular and systems biology, process engineering, and economy will have to be combined for the development of eff ... more
Über CHEMIE.DE
CHEMIE.DE Information Service GmbH runs specialist scientific internet portals. The secret to our success? We are familiar with what we publish.
Advertising at CHEMIE.DE
Our advertising formats support you in getting your message across to a clearly defined target audience.
© 1997-2013 CHEMIE.DE Information Service GmbH, All rights reserved
Netmeeting
